We have totally synthesized a gene that codes for rat hepatic cytochrome b5. The 5' flanking region was designed for efficient expression of this gene in Escherichia coli by incorporating an optimum ribosome binding site and spacer region. Both a soluble form, analogous to the protease-treated microsomal protein, as well as the complete cytochrome with hydrophobic membrane anchor, was constructed and expressed. Transformants with the gene for the soluble protein overproduce authentic cytochrome b5 to a level of 8% of the total cell protein. The complete cytochrome is expressed to a lesser extent with most of the protein found in the cell membrane fraction. This represents complete synthesis and bacterial expression of a mammalian metalloprotein gene. Cytochrome b5 is normally a six-coordinate low spin heme protein with histidine-39 and histidine-63 as axial ligands. We have replaced histidine-63 with a methionine residue by cassette mutagenesis, utilizing specific restriction enzyme sites engineered into the synthetic gene. The resultant protein has histidine-39 as sole axial ligand and is five-coordinate high spin in the ferric resting state, as indicated by optical and electron spin resonance spectroscopy. The ability to generate mutant cytochrome b5 in high yield is a crucial step in understanding heme protein folding, protein-protein recognition and binding, and biological electron transfer processes.
Cytochrome b5 is a small heme protein that plays a central role in a variety of electron transfer reactions related to fatty acid desaturation (1-3), hepatic cytochrome P-450 reduction (4) (5) (6) (7) , and regeneration offerrous hemoglobin in erythrocytes (8, 9) . The complete hepatic protein is composed of two domains, a soluble heme-containing core and a hydrophobic COOH-terminal tail anchored in the microsomal membrane (10) , whereas erythrocyte cytochrome b5 acts as a soluble agent in cytoplasmic hemoglobin reduction. The amino acid sequence of hepatic cytochrome b5 from several species has been determined, and their primary structures are highly conserved (11, 12) . The three-dimensional crystal structure ofthe tryptic fragment ofbovine liver cytochrome b5 has been determined by x-ray diffraction to a resolution of 2 A (13) . A multitude of spectroscopic, kinetic, and magnetic resonance techniques have been applied to this cytochrome and its interaction with physiological and nonphysiological electron transfer partners. The wealth of this molecular information makes cytochrome b5 an ideal target for site-directed mutagenesis experiments designed to probe the molecular mechanisms of electron transfer, the control ofheme protein redox potential, the specificity of protein-protein interactions, and the dynamics of heme protein folding. These endeavors would be greatly aided by efficient expression of the mammalian cytochrome b5 coding sequences in a microbial system. Unfortunately, past attempts at the expression of mammalian proteins in microbial hosts have met with limited success (14, 15) . For example, constructions in which a cDNA clone of myoglobin or hemoglobin are juxtaposed to an RNA polymerase promoter, ribosome binding site, and translation initiator codon of a suitable expression vector have not resulted in the synthesis of measurable heme protein. If these mammalian cDNA sequences are fused to short regions of the C1I gene, small amounts of holoprotein can be synthesized in Escherichia coli and subsequently cleaved from the fusion protein by proteolytic digestion. It is not known whether the lack of high-level production of mammalian heme proteins in E. coli is due to lack of mRNA or protein stability, difficulty in translation as a result of a poor choice of codon usage, or by the inability of E. coli to synthesize heme at rates necessary for efficient incorporation into the nascent polypeptide chain.
To address these questions and provide a means for producing native and mutant cytochrome b5 in the large quantities and high purity needed for biophysical measurements, we have utilized de novo gene synthesis, involving annealing and ligation of separately synthesized singlestranded oligodeoxyribonucleotides that together constitute the coding sequence for the catalytic soluble core, or the complete molecule of rat hepatic cytochrome b5. Included are a 5' flanking region containing a unique bacterial ribosome binding site, optimized spacer region, and initiator methionine. This approach also allows the choice of codons optimized for translation in E. coli and insertion of unique restriction endonuclease sites to aid various DNA manipulations. The ligated product of these synthetic genes was cloned into a plasmid (pUC13) and transformed into E. coli. Transformants containing the soluble core of cytochrome b5 produce holoprotein containing the protoporphyrin IX prosthetic group in amounts up to 8% of the total cellular protein, with the transformed cells containing the cytochrome b5 sequences appearing bright red due to high protein production and efficient heme incorporation. The complete cytochrome b5 gene including the membrane anchor domain is also efficiently expressed in E. coli, with incorporation of the holoprotein into the membrane fraction of the cell. Cytochrome b5 isolated and purified to homogeneity from E. coli by successive ion exchange and sizing chromatography was found to have the same physical properties and NH2-terminal amino acid sequence as the corresponding mammalian liver microsomal protein. The results described in this communication represent complete synthesis and bacterial expression of a mammalian membrane metalloprotein gene.
This successful expression of cytochrome b5 also dictates that the same methods can be used to construct mutant cytochrome b5 forms with alterations at specifically selected amino acids within the product protein. This communication demonstrates the utility of this approach for production of mutant cytochromes b5 with our report of the construction and expressions of genes coding for mutant cytochrome b5 containing specific amino acid substitutions at the histidine-63 site known to function in the axial ligand binding of the heme of cytochrome b5.
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ALA LYS PRO SFR GLU THR LEU protease solubilized fraction from hepatic microsomal membranes as shown in Fig. 1 (Fig. 3) . The absorption difference spectrum between the oxidized and reduced forms of the engineered gene product also agrees with that of the tryptic cytochrome b5 purified from mammalian tissue, having a characteristic minimum at 409 nm and a maximum at 424 nm with a differential extinction coefficient of 190 mM-lcm-1. The synthetically constructed soluble segment of cytochrome b5 is predicted to have a molecular weight of 13, 603 acids plus the heme prosthetic group), which is confirmed by gel electrophoretic analyses of the purified protein isolated from transformed E. coli cells (data not shown). Sequential Edman degradation of 4 nmol of the purified protein by an Applied Biosystems sequencer yields an alanine aminoterminal (3 nmol) residue and the 13 subsequent residues Glu (1.4 nmol), Gln (2 nmol), Ser (0.2 nmol), Asp (0.7 nmol), Lys (2.5 nmol), Asp (0.9 nmol), Val (2.7 nmol), Lys (2.0 nmol), Tyr (1.3 nmol), Tyr (1.0 nmol), Thr (0.1 nmol), Leu (2.8 nmol), and Glu (1. 1 nmol) that are identical with the native rat liver cytochrome b5 sequence, demonstrating that a lac fusion protein is not produced and that there is a complete removal of the formyl methionine initiator codon. Total amino acid analysis confirms the expected amino acid composition predicted by the coding sequence. The purified protein is low spin in the ferric resting state, being characterized by ESR g values of 1.41, 2.22, and 3.05-completely identical to values in the literature.
Full understanding of the molecular basis for electron transfer and protein-protein interaction between cytochrome b5 and its electron transfer partners requires studies with the complete cytochrome b5 protein, including the hydrophobic membrane domain. We thus extended our gene synthesis effort with eight additional oligodeoxyribonucleotides (Fig.  4) to generate the coding sequence for the entire microsomal membrane protein. Our approach utilized the Xho I restriction endonuclease site of the synthetic soluble domain to accommodate oligodeoxyribonucleotides comprising the coding sequence of the membrane anchor and providing a unique Bcl I restriction site at thejunction ofthe two domains prior to translation termination (Fig. 4) . The complete cytochrome b5 construction was verified by Sanger sequencing.
Cells transformed with recombinant plasmids containing the complete cytochrome b5 gene express 41/10th as much cytochrome b5 as cells containing the synthetic gene for the soluble domain of cytochrome b5, as judged by whole-cell optical spectroscopy and NaDodSO4/PAGE. NaDodSO4/ PAGE analyses of subcellular fractions of cells expressing this complete gene for mammalian cytochrome b5 establish that much ofthe complete protein product copurifies with the bacterial membrane, although some of the expressed protein is also found in the cytoplasmic fraction (Fig. 2) . Detergent solubilization and purification readily purifies this membrane-associated form of cytochrome b5.
The successful engineering, cloning, and expression of a gene for both the soluble catalytic core segment and the complete membrane-associated form of cytochrome b5 provides an excellent means for obtaining large amounts of purified protein for biophysical and chemical studies. More importantly, this method of genetic engineering allows us to clone and express a wide variety of mutant cytochrome b5 structures with specifically altered amino acids. Primary targets for our initial mutagenesis studies include substitution of the histidine axial ligands (histidine-39 and histidine-63), alteration of surface charge distributions, modification of the hydrophobic membrane anchor domain, and modification of residues that potentially control the redox potential and electron transfer rate in this important cytochrome of mammalian physiology.
To demonstrate the utility of this approach, we chose to alter the histidine axial ligand at amino acid position 63. A prime consideration in selecting the amino acid to be replaced at this site is the realization that altered amino acid side chains in an interior structure of a protein can potentially generate large interstitial spaces that can be occupied by solvent. This is particularly important near the regions of cytochrome b5 structure, which provide close van der Waals contact with the hydrophobic surface of the protoporphyrin IX prosthetic group. Replacement of histidine-63 with an alanine-63 by cassette mutagenesis, schematically illustrated in Fig. 1 , yields a protein that fails to incorporate heme during cell fermentation and that is not reconstituted with exogenous heme after purification of the apoprotein. Mutant cytochrome b5 protein with a methionine substitution at position 63 served two experimental purposes depending on whether the methionine residue would form a functional coordinate bond to the heme iron. Examination of the native and proposed mutant structures of the catalytic core of cytochrome b5 on an IRIS 2400 molecular graphics system suggests that the methionine sulfur would be at too great a distance from the heme iron to form an axial ligand unless substantial movement of the prosthetic group were to take place. If sufficient structural relaxation did occur, a histidine-39-methionine-63 ligation scheme would mimic the ligand structure of the c-type cytochromes with their well-defined optical and magnetic resonance properties. The extra volume of the methionine side chain, however, should in any case tend to exclude water from the porphyrin surface and hence favor prosthetic group incorporation. Generation of a methionine-63 mutation ofthe soluble form ofcytochrome b5 as described Attachment of the membrane anchor fragment to the soluble cytochrome b5 generates an intact cytochrome that is primarily inserted into the membrane fraction of E. coli. This represents the first example of the incorporation of a foreign mammalian membrane protein into a bacterial bilayer compartment. At present, the reason for the somewhat lower expression of the complete cytochrome b5 gene is not understood.
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The incorporation of restriction sites surrounding the heme axial ligands of cytochrome b5 has allowed conversion of this normal six-coordinate low-spin heme protein to a fivecoordinate high-spin cytochrome by replacing histidine-63 with a methionine ligand. This modified protein is able to reversibly bind exogenous ligands such as carbon monoxide. The ability to alter metal ligation geometry in metalloproteins opens up the exciting possibility of understanding the role of ligand geometry and type in determining metal site reactivity and physical and spectroscopic properties.
